Inclusive Health Research awards celebrate community projects driving health equity globally
Groundbreaking projects in crisis support for sexual and gender minorities, disabled health outcomes, and long COVID recognised as winners of the second Inclusive Health Research awards by Nature and Takeda.
London | Cambridge, US | Cape Town, SA, 24 October 2024
The Nature Awards for Inclusive Health Research, in partnership with Takeda, is proud to mark its second year by recognising the following projects for driving inclusivity in health research and seeking to improve health equity across the globe:
- The Dignity Project - Kelsey Chapman, Griffith University, Australia - A project to collect data from citizen scientists with disabilities to design dignified services and systems, enhancing health outcomes and equity. Using a bespoke digital engagement platform, the project uses storytelling to ensure inclusive and impactful research is driven by more than 700 people with lived experience.
- Profiling the Determinants of Long COVID - Mark Faghy, University of Derby, UK - A research project to combine the pathophysiology data with the lived experience of patients being impacted by Long COVID. The research was designed and conducted with patients, for the benefit of the entire Long COVID community.
- RISE Study ("Resist, Intervene, Support, Empower"): Addressing the impact of violence among queer women from Brazil - Monica Malta, University of Toronto, Canada. - An app addressing the high levels of violence and poverty among sexual and gender minorities (SGM) in Brazil by mapping and reporting violence, as well as offering 24/7 crisis support.
The winners were announced following a Nature Forum event on Health Equity hosted by Stellenbosch University at their Tygerberg Campus in Cape Town.
Helena Jensen, Head of Grants & Awards, Springer Nature, commented: “Promoting and championing equity across the research space is central to the ethos of the Nature Awards. Why? Because global equity in life sciences research has a key role in improving the quality, plurality and inclusivity of healthcare outcomes. With this year’s awards, we have once again seen a wealth of inspiring projects, each demonstrating the power inclusivity and collaboration can have on addressing global health needs. Through this award with Takeda, we seek to recognise impactful contributions to advancing health equity globally and send our congratulations to this year’s winners for the outstanding work they are doing.”
The awards and the conference form part of an ongoing programme of activities on health equity delivered through Springer Nature and Takeda’s partnership. Together, Springer Nature and Takeda aim to build awareness of key issues through storytelling, convening thought leaders to identify solutions, and encouraging the adoption of best practices.
More on the partnership can be found here.
####
Notes to Editors:
RISE Study ("Resist, Intervene, Support, Empower"): Addressing the impact of violence among queer women from Brazil, The Dignity Project, and Profiling the Determinants of Long COVID study each received a €20,000 cash prize.
The funds must be used in line with the spirit and goals of this award to develop a more inclusive health research ecosystem. As such it can be used to support the development of the project towards positive impact.
Further information can be found on the awards page here.
The Nature Forum took place on 23 October at the Tygerberg Campus, Cape Town, South Africa. Speakers included: Ben Johnson, Nature Medicine; Jean Kaseya, Africa CDC; Joshua Kimani, Partners for Health and Development in Africa; Kelly Chibale, University of Cape Town; Lynn Hendricks, Stellenbosch University.
A library of case studies that demonstrate best practice in inclusive health research from the awards winners and other highly commended applicants can be found on our dedicated web page.
ENDS
At Springer Nature, we are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world. Every day our books, journals, platforms, and technology solutions reach millions of people; helping researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. Through our leading brands, trusted for more than 180 years, and our steadfast commitment to the most rigorous standards, we help accelerate solutions to the world’s urgent challenges and inspire generations to come. For more information, please visit about.springernature.com and @SpringerNature.
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit https://www.takeda.com
Springer Nature | Corporate Affairs | Theodore HibbertGreaves
